TLRY
Tilray Brands, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$2.50
−5.27%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.33x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.23x
- Price / sales
- 0.38x
- Price / cash flow
- -4.20x
Enterprise value
- Enterprise value
- $506.8M
- EV / sales
- 0.53x
- EV / EBITDA
- -27.36x
- EV / EBIT
- -6.56x
- Market cap
- $369.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Aug 1, 2026